Table 3.
Description of the proportion of variants in the repeated samples from six patients based on three DNA target regions analyzed using UDPS.
| Patient N° | Sample N° | Specimen | Delay from first sample (days) | mtLSU variants (%) | ITS2 variants (%) | DHFR variants (%) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TT | TC | CT | CC | AT | AC | TAT | ATG | TTG | TTA | AAG | AAA | ATC | TA | CA | TG | ||||
| P2 | Pj_SLS_030 | Sputum | 2.9 | 97.0 | 0.5 | 99.5 | 15.2 | 84.5 | |||||||||||
| Pj_SLS_032 | BAL | +2 | 5.6 | 94.3 | 25.4 | 73.4 | 1.3 | 7.5 | 92.5 | ||||||||||
| P3 | Pj_SLS_045 | BAL | 6.9 | 4.3 | 84.0 | 4.7 | 0.5 | 99.5 | 100.0 | ||||||||||
| Pj_SLS_053 | BAL | +14 | 4.6 | 2.5 | 91.1 | 1.8 | 1.7 | 97.9 | 96.5 | 1.7 | |||||||||
| P14 | Pj_SLS_197 | Sputum | 96.4 | 0.7 | 2.5 | 1.2 | 74.1 | 24.8 | 100.0 | ||||||||||
| Pj_SLS_199 | BAL | +1 | 96.8 | 2.5 | 1.4 | 97.5 | 1.2 | 100.0 | |||||||||||
| P18 | Pj_SLS_240 | Sputum | 0.6 | 3.0 | 85.9 | 3.5 | 3.9 | 3.0 | 10.8 | 89.2 | 8.7 | 88.0 | |||||||
| Pj_SLS_243 | Sputum | +7 | 1.2 | 10.0 | 81.2 | 3.1 | 1.8 | 2.7 | 0.8 | 99.3 | 6.1 | 91.3 | |||||||
| P24 | Pj_SLS_272 | Sputum | 1.9 | 92.5 | 0.7 | 2.6 | 2.2 | 0.7 | 94.4 | 4.7 | 11.6 | 88.4 | |||||||
| Pj_SLS_282 | BAL | +18 | 95.9 | 1.7 | 1.0 | 1.1 | 8.8 | 89.8 | 1.4 | 4.1 | 94.7 | ||||||||
| P25 | Pj_SLS_317 | Sputum | 41.8 | 8.1 | 3.5 | 46.3 | 0.6 | 39.1 | 59.2 | 1.0 | 100.0 | ||||||||
| Pj_SLS_321 | BAL | +8 | 79.5 | 7.4 | 4.0 | 8.9 | 4.3 | 94.9 | 0.7 | 68.3 | 30.4 | ||||||||